Question 1

What is Risankizumab used for?

Accepted Answer

Risankizumab (brand name Skyrizi) is a Biologic (IL-23 Inhibitor) indicated for Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease.

Question 2

How does Risankizumab work?

Accepted Answer

Risankizumab works through the following mechanism: Humanized monoclonal antibody that selectively binds to the p19 subunit of IL-23, inhibiting IL-23-dependent inflammatory signalling..

Question 3

What are the most common side effects of Risankizumab?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for Risankizumab. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is Risankizumab the same as Skyrizi?

Accepted Answer

Skyrizi is a brand name for Risankizumab. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

Risankizumab

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations